SLP
Simulations Plus, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$18.44
+0.13%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 82.1M | 79.2M | 70.0M | 59.6M | 53.9M |
| Cost of Revenue | 30.1M | 33.0M | 26.9M | 11.6M | 10.8M |
| Gross Profit | 52.0M | 46.2M | 43.2M | 47.9M | 43.1M |
| Operating Expenses | |||||
| R&D Expense | 11.5M | 6.9M | 5.8M | 4.5M | 3.2M |
| SG&A Expense | 29.0M | 32.8M | 31.3M | 34.7M | 25.0M |
| General & Admin Expense | 17.7M | 20.9M | 22.4M | 28.2M | 20.1M |
| Selling & Marketing Expense | 11.3M | 11.9M | 8.9M | 6.6M | 4.9M |
| Other Expenses | — | 77.2M | — | — | — |
| Total Operating Expenses | 40.5M | 117.0M | 37.0M | 39.2M | 28.2M |
| Cost and Expenses | 70.6M | 149.9M | 63.9M | 50.9M | 39.0M |
| Operating Income (EBIT) | 11.5M | (70.7M) | 6.1M | 8.7M | 14.9M |
| Non-Operating | |||||
| Interest Income | 1.1M | 722.0K | 4.4M | 4.1M | 717.0K |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 1.1M | 722.0K | 4.4M | 4.1M | 717.0K |
| Other Non-Op Income/Expense | 1.1M | 1.4M | 6.3M | 3.0M | 204.0K |
| Non-Operating Income (excl Interest) | (230.0K) | (77.2M) | (6.3M) | (500.0K) | (204.0K) |
| EBT (Pre-Tax Income) | 12.6M | (69.4M) | 12.4M | 11.7M | 15.1M |
| Income Tax Expense | 4.4M | (4.7M) | 2.5M | 1.7M | 2.6M |
| Bottom Line | |||||
| Net Income | 8.1M | (64.7M) | 10.0M | 10.0M | 12.5M |
| Earnings from Cont. Ops | 8.1M | (64.7M) | 10.0M | 10.0M | 12.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 8.1M | (64.7M) | 10.0M | 10.0M | 12.5M |
| Per Share | |||||
| Basic EPS | $0.41 | ($3.22) | $0.50 | $0.50 | $0.62 |
| Diluted EPS | $0.40 | ($3.22) | $0.49 | $0.49 | $0.60 |
| Revenue Per Share | $4.07 | $3.94 | $3.50 | $2.97 | $2.67 |
| Shares | |||||
| Basic Shares Outstanding | 20.2M | 20.1M | 20.0M | 20.1M | 20.2M |
| Diluted Shares Outstanding | 20.2M | 20.1M | 20.3M | 20.5M | 20.7M |
| Profitability Metrics | |||||
| EBITDA | 13.1M | 14.7M | 18.1M | 13.1M | 18.7M |
| D&A | 1.4M | 8.2M | 5.7M | 3.8M | 3.6M |
| EBIT | 11.7M | 6.5M | 12.4M | 9.2M | 15.1M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of May 1, 2026